Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Health Catalyst Inc shares valued at $12,251 were sold by Llewelyn Linda on Apr 15 ’24. At $6.11 per share, Llewelyn Linda sold 2,005 shares. The insider’s holdings dropped to 126,226 shares worth approximately $0.76 million following the completion of this transaction.
Also, Llewelyn Linda sold 2,005 shares, netting a total of over 15,648 in proceeds. Following the sale of shares at $7.80 each, the insider now holds 128,231 shares.
Before that, Burton Daniel D. had added 26,200 shares to its account. In a trade valued at $204,525, the Chief Executive Officer bought Health Catalyst Inc shares for $7.81 each. Upon closing the transaction, the insider’s holdings increased to 26,200 shares, worth approximately $7.07 million.
As published in a research note from KeyBanc Capital Markets on April 10, 2024, Health Catalyst Inc [HCAT] has been rated down from an Overweight to a Sector weight. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in early January. As of January 03, 2024, Barclays has initiated its “an Overweight” rating for HCAT. Earlier on December 13, 2023, JP Morgan upgraded its rating. Their new recommendation was “an Overweight” for HCAT stock which previously was a “a Neutral”.
Analyzing HCAT Stock Performance
During the last five days, there has been a surge of approximately 7.20%. Over the course of the year, Health Catalyst Inc shares have dropped approximately -34.88%. Shares of the company reached a 52-week high of $11.41 on 01/12/24 and a 52-week low of $5.45 on 04/23/24. A 50-day SMA is recorded $7.59, while a 200-day SMA reached $9.38. Nevertheless, trading volume fell to 0.78 million shares from 0.6 million shares the previous day.
Support And Resistance Levels for Health Catalyst Inc (HCAT)
According to the 24-hour chart, there is a support level at 5.71, which, if violated, would cause prices to drop to 5.40. In the upper region, resistance lies at 6.20. The next price resistance is at 6.38. RSI (Relative Strength Index) is 38.40 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.26, which suggests the price will decrease in the coming days. Percent R is at 59.66%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.
